RHE-70202

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRHE-70202
Drug Alias NameRHE-70202
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionInterleukin-1 alpha inhibitors
TargetsInterleukin-1 alpha
Therapy Area/IndicationsArthritis, Psoriatic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesXbiotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesXbiotech Inc
Inactive CompaniesN/A
Active IndicationsArthritis, Psoriatic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A